These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 31841737)

  • 1. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
    Shi Z; Qiu Y; Wang J; Fang Y; Zhang Y; Chen H; Du Q; Zhao Z; Yan C; Yang M; Zhou H
    J Neuroimmunol; 2020 Feb; 339():577126. PubMed ID: 31841737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Barrier Breakdown and Mucosal Microbiota Disturbance in Neuromyelitis Optical Spectrum Disorders.
    Cui C; Tan S; Tao L; Gong J; Chang Y; Wang Y; Fan P; He D; Ruan Y; Qiu W
    Front Immunol; 2020; 11():2101. PubMed ID: 32983166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic of gut microbiota in southeastern Chinese patients with neuromyelitis optica spectrum disorders.
    Zhang J; Xu YF; Wu L; Li HF; Wu ZY
    Mult Scler Relat Disord; 2020 Sep; 44():102217. PubMed ID: 32534438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of short-chain fatty acids and overgrowth of opportunistic pathogens define dysbiosis of neuromyelitis optica spectrum disorders: A Chinese pilot study.
    Gong J; Qiu W; Zeng Q; Liu X; Sun X; Li H; Yang Y; Wu A; Bao J; Wang Y; Shu Y; Hu X; Bellanti JA; Zheng SG; Lu Y; Lu Z
    Mult Scler; 2019 Aug; 25(9):1316-1325. PubMed ID: 30113252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab-induced gut microbiota changes in Chinese neuromyelitis optica spectrum disorders.
    Chen H; Xu Z; Zhou Y; Jiang YH; Chen J; Xiong Y; Zhou M; Wu X; Hong D
    Mult Scler Relat Disord; 2024 Jun; 86():105606. PubMed ID: 38636269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of gastrointestinal toxicity in neuromyelitis optica spectrum disorder patients treated with mycophenolate mofetil: insights from a mouse model and human study.
    Li G; Xia L-J; Shu Y-Q; Wan L; Huang Q; Ma X-Y; Zhang H-Y; Zheng Z-J; Wang X-R; Zhou S-Y; Gao A; Ren H; Lian X-L; Xu D; Tang S-Q; Liao X-P; Qiu W; Sun J
    Microbiol Spectr; 2024 Aug; 12(8):e0430723. PubMed ID: 38916339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perturbed microbial ecology in neuromyelitis optica spectrum disorder: Evidence from the gut microbiome and fecal metabolome.
    Xie Q; Sun J; Sun M; Wang Q; Wang M
    Mult Scler Relat Disord; 2024 Dec; 92():105936. PubMed ID: 39418776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
    Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
    J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of the gut microbiota in neuromyelitis optica spectrum disorder: Implication for intervention.
    Cui C; Ruan Y; Qiu W
    J Clin Neurosci; 2020 Dec; 82(Pt B):193-199. PubMed ID: 33257156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the gut microbiota in patients with chronic kidney disease.
    Hu X; Ouyang S; Xie Y; Gong Z; Du J
    Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
    [No Abstract]   [Full Text] [Related]  

  • 13. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.
    Zhang YL; Cai LT; Qi JY; Lin YZ; Dai YC; Jiao N; Chen YL; Zheng L; Wang BB; Zhu LX; Tang ZP; Zhu RX
    World J Gastroenterol; 2019 Jul; 25(25):3242-3255. PubMed ID: 31333315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of purine metabolites and gut microbiota in patients with neuromyelitis optica spectrum disorders after mycophenolate mofetil treatment.
    Li G; Ma X; Xia L; Wei R; Wang X; Li C; Wang Y; He L; Ren H; Sun J; Qiu W
    BMC Neurol; 2023 Dec; 23(1):444. PubMed ID: 38102573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
    Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
    Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the Gut Microbiota in Hashimoto's Thyroiditis Patients.
    Zhao F; Feng J; Li J; Zhao L; Liu Y; Chen H; Jin Y; Zhu B; Wei Y
    Thyroid; 2018 Feb; 28(2):175-186. PubMed ID: 29320965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota dysbiosis is associated with Henoch-Schönlein Purpura in children.
    Wang X; Zhang L; Wang Y; Liu X; Zhang H; Liu Y; Shen N; Yang J; Gai Z
    Int Immunopharmacol; 2018 May; 58():1-8. PubMed ID: 29525681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
    Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
    Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.